Annual Disclosure under Regulation 31(4) of SEBI (SAST) Regulation, 2011, received from the Promoter and Promoter Group is enclosed.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mahamaya Lifesciences Ltd has filed its annual disclosure under SEBI's Takeover Regulations. The Promoter and Promoter Group, represented by Managing Director Krishnamurthy Ganesan, have confirmed that no encumbrance (pledge) was created on their shares during the financial year ended 31 March 2026. This is a standard regulatory filing that ensures transparency about promoter shareholdings. The disclosure was submitted to BSE Limited for the record.
Positive signal for retail investors as it confirms promoters have not pledged their shares, reducing the risk of forced selling and potential downward pressure on the stock price.